Literature DB >> 33040231

Personalized treatment for coronary artery disease patients: a machine learning approach.

Dimitris Bertsimas1, Agni Orfanoudaki2, Rory B Weiner3.   

Abstract

Current clinical practice guidelines for managing Coronary Artery Disease (CAD) account for general cardiovascular risk factors. However, they do not present a framework that considers personalized patient-specific characteristics. Using the electronic health records of 21,460 patients, we created data-driven models for personalized CAD management that significantly improve health outcomes relative to the standard of care. We develop binary classifiers to detect whether a patient will experience an adverse event due to CAD within a 10-year time frame. Combining the patients' medical history and clinical examination results, we achieve 81.5% AUC. For each treatment, we also create a series of regression models that are based on different supervised machine learning algorithms. We are able to estimate with average R2 = 0.801 the outcome of interest; the time from diagnosis to a potential adverse event (TAE). Leveraging combinations of these models, we present ML4CAD, a novel personalized prescriptive algorithm. Considering the recommendations of multiple predictive models at once, the goal of ML4CAD is to identify for every patient the therapy with the best expected TAE using a voting mechanism. We evaluate its performance by measuring the prescription effectiveness and robustness under alternative ground truths. We show that our methodology improves the expected TAE upon the current baseline by 24.11%, increasing it from 4.56 to 5.66 years. The algorithm performs particularly well for the male (24.3% improvement) and Hispanic (58.41% improvement) subpopulations. Finally, we create an interactive interface, providing physicians with an intuitive, accurate, readily implementable, and effective tool.

Entities:  

Keywords:  Coronary artery disease; Machine learning; Personalization; Precision medicine; Prescriptions

Mesh:

Year:  2020        PMID: 33040231     DOI: 10.1007/s10729-020-09522-4

Source DB:  PubMed          Journal:  Health Care Manag Sci        ISSN: 1386-9620


  7 in total

Review 1.  Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?

Authors:  Hasitha Manohar; Adam S Potter; Efstratios Koutroumpakis; Anita Deswal; Nicolas L Palaskas
Journal:  Curr Atheroscler Rep       Date:  2022-05-28       Impact factor: 5.967

Review 2.  Nano-Technological Approaches for Targeting Kidney Diseases With Focus on Diabetic Nephropathy: Recent Progress, and Future Perspectives.

Authors:  Bo Lin; Ying-Yu Ma; Jun-Wei Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

3.  Diagnostic Policies Optimization for Chronic Diseases Based on POMDP Model.

Authors:  Wenqian Zhang; Haiyan Wang
Journal:  Healthcare (Basel)       Date:  2022-02-01

Review 4.  Current and Future Applications of Artificial Intelligence in Coronary Artery Disease.

Authors:  Nitesh Gautam; Prachi Saluja; Abdallah Malkawi; Mark G Rabbat; Mouaz H Al-Mallah; Gianluca Pontone; Yiye Zhang; Benjamin C Lee; Subhi J Al'Aref
Journal:  Healthcare (Basel)       Date:  2022-01-26

5.  Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients.

Authors:  Agni Orfanoudaki; Holly Wiberg; Dimitris Bertsimas; Alison Borenstein; Luca Mingardi; Omid Nohadani; Bartolomeo Stellato; Pankaj Sarin; Dirk J Varelmann; Vicente Estrada; Carlos Macaya; Iván J Núñez Gil
Journal:  Health Care Manag Sci       Date:  2021-03-15

6.  Compliance with medical recommendations depending on the use of artificial intelligence as a diagnostic method.

Authors:  Michaela Soellner; Joerg Koenigstorfer
Journal:  BMC Med Inform Decis Mak       Date:  2021-08-06       Impact factor: 2.796

7.  Machine Learning Predictive Models for Coronary Artery Disease.

Authors:  L J Muhammad; Ibrahem Al-Shourbaji; Ahmed Abba Haruna; I A Mohammed; Abdulkadir Ahmad; Muhammed Besiru Jibrin
Journal:  SN Comput Sci       Date:  2021-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.